著者: HaenischBritta, BönischHeinz

原題: Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor.

著者: SangerGareth J

原題: 5-hydroxytryptamine and the gastrointestinal tract: where next?

著者: Vazquez RoqueMaria, CamilleriMichael

原題: Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation.

著者: AdamBirgit, LiebregtsTobias, GerkenGuido

原題: [New drugs for the treatment of constipation].

著者: BeglingerC

原題: Tegaserod: a novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome.

著者: SchoenfeldP

原題: Review article: the safety profile of tegaserod.

著者: HanX, QuinneyS K, WangZ, ZhangP, DukeJ, DestaZ, ElmendorfJ S, FlockhartD A, LiL

原題: Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach.

著者: SanakaM R, SuperD M, MullenK D, FergusonD R, McCulloughA J

原題: Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double-blind, placebo-controlled study.

著者: ZhuLingping, MaYunhui, DengXiaoyan

原題: Comparison of acupuncture and other drugs for chronic constipation: A network meta-analysis.

著者: LivioF, BuclinT, BiollazJ

原題: [Pharmacovigilance update].

著者: De MaeyerJ H, LefebvreR A, SchuurkesJ A J

原題: 5-HT4 receptor agonists: similar but not the same.

著者: SchillerLawrence R, JohnsonDavid A

原題: Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.

著者: GurbelPaul A, BlidenKevin, BarnettScott D, WittCasey, ZouHeng, TantryUdaya

原題: An Ex Vivo Study to Evaluate the Effect of Tegaserod on Platelet Activation and Aggregation.

著者: HadleySusan K, GaarderStephen M

原題: Treatment of irritable bowel syndrome.

著者: SaadRichard, CheyWilliam D

原題: Tegaserod in the treatment of irritable bowel syndrome with constipation.

著者: SangerG J

原題: Translating 5-HT receptor pharmacology.

著者: ShahRashmi R

原題: Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

著者: MertzHoward

原題: Psychotherapeutics and serotonin agonists and antagonists.

著者: ChangHoward Y, LemboAnthony J

原題: Opioid-induced bowel dysfunction.

著者: SoubraMahmoud, ScheyRon

原題: Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.

著者: FriedenbergFrank K, ParkmanHenry P

原題: Delayed gastric emptying: whom to test, how to test, and what to do.

著者: MikamiTadayoshi, OchiYasuo, SuzukiKeiko, SaitoToshiyuki, SugieYutaka, SakakibaraMinoru

原題: 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.

著者: McGuireCian, BoundoukiGeorge, HockleyJames R F, ReedDavid, Cibert-GotonVincent, PeirisMadusha, KungVictor, BroadJohn, AzizQasim, ChanChristopher, AhmedShafi, ThahaMohamed A, SangerGareth J, BlackshawL Ashley, KnowlesCharles H, BulmerDavid C

原題: Ex vivo study of human visceral nociceptors.

著者: TalleyNicholas J

原題: Pharmacologic therapy for the irritable bowel syndrome.

著者: TalleyNicholas J

原題: Update on the role of drug therapy in non-ulcer dyspepsia.

著者: ShahS H A, JafriS W, GulM, MohsinA, AfzalM N, ButtJ A, KhanI, NaqviA, RasheedI

原題: Efficacy and tolerability of tegaserod in constipation dominant irritable bowel syndrome.

著者: NiewinnaKarolina, ZielińskaAnna, FichnaJakub

原題: Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome.